Cybin Inc. (NEO:CYBN)
10.25
-0.15 (-1.44%)
Jul 30, 2025, 9:30 AM EDT
Cybin Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
50
Market Cap
240.18M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | - | - | - |
Mar 31, 2024 | - | - | - |
Mar 31, 2023 | - | - | - |
Mar 31, 2022 | - | - | - |
Mar 31, 2021 | 864.00K | - | - |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Green Thumb Industries | 1.64B |
Sienna Senior Living | 896.45M |
dentalcorp Holdings | 1.58B |
Curaleaf Holdings | 1.89B |
Trulieve Cannabis | 1.71B |
WELL Health Technologies | 990.34M |
Cronos Group | 179.08M |
Extendicare | 1.47B |
Cybin News
- 13 days ago - Cybin Receives UK MHRA Approval to Commence EMBRACE, A Multinational Pivotal Study Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder - Business Wire
- 4 weeks ago - REPEAT/Cybin Announces Financing of up to US$500 Million Aggregate Principal Amount of Convertible Debentures - Business Wire
- 4 weeks ago - Cybin reports Q4 results - Seeking Alpha
- 4 weeks ago - Cybin Reports Fiscal Year 2025 Financial Results and Recent Business Highlights - Business Wire
- 4 weeks ago - Cybin Announces Financing of up to US$500 Million Aggregate Principal Amount of Convertible Debentures - Business Wire
- 6 weeks ago - Cybin Provides Corporate Update and Highlights Positive Regulatory Signals for Psychedelic Therapeutics - Business Wire
- 6 weeks ago - Cybin to Participate in the H.C. Wainwright 6th Annual Neuro Perspectives Conference - Business Wire
- 7 weeks ago - Cybin to Participate in the 2025 Psychedelic Science Conference - Business Wire